My Glycomet order has arrived in Edmonton. Where do I find the lot number and expiry date?
Check the medicine packaging label for the lot number and expiry date. Keep the package with the tablets so these details remain available.
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 30 | C$1.20 | - | C$36.06 | |
| 60 | C$0.93 | C$16.07 | C$56.05 | |
| 90 | C$0.85 | C$31.87 | C$76.31 | |
| 180 | C$0.76 | C$78.97 | C$137.39 |
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 180 | C$0.33 | - | C$59.40 | |
| 270 | C$0.30 | C$9.29 | C$79.81 | |
| 360 | C$0.28 | C$18.45 | C$100.35 |
Your order is carefully packed and ships within 24 hours. Here's the typical package.
Sized like a regular personal letter (24x11x0.7 cm), with no indication of its contents.
| Shipping Method | Estimated delivery |
|---|---|
| Express Free for orders over C$419.30 | Estimated delivery to Canada: 4-7 days |
| Standard Free for orders over C$279.53 | Estimated delivery to Canada: 14-21 days |










| Country | Brand Names |
|---|---|
Canada | Apo-Metformin Glucophage |
United States | Glucophage Glumetza |
United Kingdom | Glucophage |
France | Glucophage |
Australia | Diabex Diaformin |
Germany | Glucophage Siofor |
Italy | Glucophage |
Glycomet is an oral tablet form of metformin, a biguanide used to help manage blood glucose in adults with type 2 diabetes. We carry it in two strengths, 250 mg and 500 mg, and we offer each strength in a different set of package sizes. These options make it possible to match an order to the strength already selected for treatment and the number of tablets expected to be used. This guide walks through the exact packages we offer, how their unit value compares, and the practical considerations that go alongside choosing a strength and quantity.
Because Glycomet comes as an oral tablet, the main choices in our catalogue are strength, package quantity, and the resulting per-tablet value. We list 250 mg tablets in packs of 30, 60, 90, and 180, and 500 mg tablets in packs of 180, 270, and 360. Larger packages may bring the per-tablet price down, but value is not determined by unit price alone. The suitable choice must still match the strength being used, the prescribed number of tablets per dose, and the amount that can reasonably be used before the product expires.
Package quantities should be compared as tablet counts rather than assumed treatment durations. The same package can last for very different lengths of time depending on the person's daily regimen. Before ordering, it is useful to confirm the strength on the current medicine label, calculate the expected tablet requirement, and check whether a dose change or follow-up appointment is planned.
Unit value becomes clearer once package sizes are placed side by side. The comparison below focuses on our 500 mg tablets, for which we currently offer three package sizes. It shows the exact total price, price per tablet, and relative savings for each option in Canadian dollars.

A larger package can reduce how often a reorder is needed when it matches an established treatment plan. A smaller available option may be more practical when the expected tablet requirement is limited or treatment is due for review. The lower per-tablet price on a larger pack is one factor to weigh alongside expected use, storage, expiry, and the possibility that a prescriber may adjust the regimen.
When comparing packages, start with the required strength and then compare only the quantities available for that strength. A lower unit price does not create value if tablets are left unused, stored incorrectly, or ordered in a strength that does not match the intended regimen. The comparison is therefore best used as a cost tool after the medical choice has already been established.
The table below sets out which package sizes we offer at each strength, separate from pricing, so the available combinations are easy to scan.
| Strength | Package sizes we offer (tablets) |
|---|---|
| 250 mg | 30, 60, 90, 180 |
| 500 mg | 180, 270, 360 |
Strength and tablet count are separate decisions. For example, two 250 mg tablets contain the same total amount of metformin as one 500 mg tablet, but people should not make that substitution on their own because tablet instructions, tolerability, and the prescribed schedule still matter. Metformin is generally started at a low dose and increased gradually, often no more frequently than every one to two weeks, to reduce gastrointestinal side effects. The strength and daily total that suit one person will not necessarily suit another.
Glycomet is a branded formulation of metformin hydrochloride, the same active ingredient found in other immediate-release metformin products. Choosing Glycomet rather than an unbranded tablet is mainly a matter of manufacturer and packaging consistency rather than choosing a different active medicine; the active ingredient, oral route, and immediate-release tablet form remain the same.
Some other metformin products use an extended-release formulation designed to release the medicine more gradually and, depending on the product and regimen, may be taken less frequently. That is a meaningful difference from the immediate-release Glycomet tablets we offer. Immediate-release and extended-release tablets should not be treated as automatically interchangeable, even when the labelled milligram strength looks similar.
Other oral treatments for type 2 diabetes, including sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and thiazolidinediones, work differently and have different benefits, risks, and monitoring needs. They are alternatives or additions selected according to individual clinical circumstances, not direct package-for-package substitutes for Glycomet.
Metformin is a common first-line oral treatment for type 2 diabetes and is generally used alongside diet and exercise rather than as a replacement for them. It is not indicated for type 1 diabetes or diabetic ketoacidosis. Its role may also change as kidney function, blood glucose results, other medicines, and treatment goals change over time.
Response is usually followed with home blood glucose readings where advised and periodic laboratory testing, including HbA1c. Kidney function should be assessed before treatment and monitored afterwards. Longer-term use can also reduce vitamin B12 levels in some people, so a clinician may investigate B12 if symptoms such as unusual fatigue, anaemia, or numbness develop. Readers exploring other relevant treatments can visit our Diabetes page.
Metformin lowers blood glucose mainly by reducing how much glucose the liver releases and improving how the body's tissues respond to insulin. It does not primarily work by stimulating the pancreas to release more insulin, which is why metformin used alone carries a relatively low risk of hypoglycemia.
Glycomet tablets are generally taken with meals to reduce the nausea, diarrhea, abdominal discomfort, or loss of appetite that can occur when treatment begins or the dose increases. Doses should be taken according to the schedule provided by a prescriber, and a missed dose should not be replaced with a double dose. Anyone uncertain about whether a tablet can be split or how to coordinate doses with meals should check the dispensing label or ask a pharmacist.
Improvement in blood glucose control develops with consistent use rather than after a single tablet. Some change may be measurable within days, while the fuller effect of a dose adjustment is assessed over a longer period. Continuing diet, activity, monitoring, and follow-up remains important even when glucose readings begin to improve.
Metformin labelling calls for kidney function assessment before and during treatment because impaired kidney function raises the risk of lactic acidosis, a rare but serious complication. Metformin should not be used in people with severe kidney impairment, acute or chronic metabolic acidosis, or known hypersensitivity to metformin or a tablet ingredient. Prompt medical help is important for symptoms that could indicate lactic acidosis, such as severe weakness, unusual muscle pain, breathing difficulty, increasing drowsiness, or persistent abdominal distress.
Treatment may need to be paused temporarily around procedures involving iodinated contrast media, major surgery, or periods of severe dehydration or acute illness. The clinician arranging the procedure or treating the illness should provide instructions on when to stop and restart it. Common side effects include nausea, diarrhea, abdominal discomfort, and a metallic taste, especially during the first weeks or after a dose increase.
This is general safety information rather than an individual recommendation. Anyone starting, stopping, or adjusting Glycomet should follow their prescriber's instructions and complete any requested blood tests.
Metformin is authorized for human use in Canada, and oral metformin tablets are classified as a prescription dosage form. That classification describes the medicine's regulatory status and is separate from how we process an order. We do not require a prescription to be submitted before accepting an order for Glycomet, so customers can order through our checkout without providing one in advance.
Our ordering policy does not change metformin's prescription status or replace an individual assessment. Customers should use the strength and dosing schedule selected for them and speak with a prescriber or pharmacist if they have not previously used metformin, their dose has changed, they are pregnant or breastfeeding, or they have kidney, liver, heart, or acute medical problems.
We have operated our online catalogue since 2018. Our support team is reachable by email or online chat 24 hours a day, seven days a week, and a pharmacist is available to answer product questions. Once an order for Glycomet is placed, our checkout confirms the exact strength and package quantity selected, and we pack and dispatch it for delivery to the address provided.
Reviewing the order summary is particularly important because the available package quantities differ by strength. The 30, 60, and 90 tablet options apply only to 250 mg in our current offer, while the 270 and 360 tablet options apply only to 500 mg. The 180 tablet quantity is available for both strengths, so the milligram strength should always be checked as well as the tablet count.
Choosing between Glycomet 250 mg and 500 mg, and between a smaller or larger package, begins with the strength and dosing schedule already selected for treatment. The next step is to estimate the realistic tablet requirement and compare the package quantities offered for that strength. Price per tablet can then help distinguish value among otherwise suitable options.
A larger package may lower the per-tablet price and reduce reorder frequency, but those advantages apply only when the quantity can be used appropriately before expiry and the treatment plan is expected to remain stable. The comparison above shows exactly how value differs across our current 500 mg packages, while the package table identifies every strength-and-quantity combination we offer. We keep the package, strength, and ordering details on this page current so the option selected at checkout is the option packed for delivery.
My Glycomet order has arrived in Edmonton. Where do I find the lot number and expiry date?
Check the medicine packaging label for the lot number and expiry date. Keep the package with the tablets so these details remain available.
I am ordering from Sherbrooke and want enough tablets for several months. Can you guarantee how much shelf life will be left?
We cannot guarantee a specific remaining shelf life before dispatch. The exact expiry date is printed on the medicine packaging you receive.
I take metformin for type 2 diabetes and my clinician is considering adding insulin. Does metformin make low blood sugar more likely with insulin?
Metformin alone does not usually cause hypoglycemia, but the risk can increase when it is used with insulin. Insulin dosing and blood-glucose monitoring need to be planned by the clinician managing your diabetes.
| Active ingredient | Metformin |
|---|---|
| Drug class | Biguanide antidiabetic |
| Dosage form | Tablet |
| Available strengths | 250 mg, 500 mg |
| Route | Oral |
| Storage | Store the tablets at 20°C to 25°C in a tightly closed container, protected from light and moisture; brief excursions between 15°C and 30°C are permitted. |
| ATC code | A10BA02 |
This product has 34 ratings, but only 6 written reviews so far. Share your experience and help other customers.
I'll be ordering again.
Packaging was well done.
Order arrived as expected.
The reply was clear when I asked which package quantities were available.
Prices were a bit lower before, but Glycomet still seems worth it for the quality.
The Glycomet order arrived within the expected delivery period.